Frady v. C. R. Bard, Inc.

CourtDistrict Court, D. Massachusetts
DecidedApril 30, 2020
Docket1:19-cv-12549
StatusUnknown

This text of Frady v. C. R. Bard, Inc. (Frady v. C. R. Bard, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Massachusetts primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Frady v. C. R. Bard, Inc., (D. Mass. 2020).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS

ANN FRADY, * * Plaintiff, * * v. * * Civil Action No. 1:19-cv-12549-ADB C. R. BARD, INC., * * Defendant. * * *

MEMORANDUM AND ORDER ON DEFENDANT’S MOTION FOR PARTIAL SUMMARY JUDGMENT

BURROUGHS, D.J. Plaintiff Ann Frady (“Plaintiff”) filed this action against Defendant C.R. Bard, Inc. (“Defendant”) asserting claims for negligence (Count I), strict liability design defect (Count II), strict liability manufacturing defect (Count III), strict liability failure to warn (Count IV), breach of express warranty (Count V), breach of implied warranty (Count VI), and punitive damages (Count VIII) in connection with complications she experienced from a device manufactured by Defendant. [ECF No. 1 at 5 (“Short-Form Compl.”); ECF No. 60-2 at 510–43 (“Long-Form Compl.”)].1 Currently pending before the Court is Defendant’s motion for partial summary judgment. [ECF No. 42]. For the reasons set forth below, Defendant’s motion for partial summary judgment, [ECF No. 42], is GRANTED.

1 Plaintiff did not allege Count VII (loss of consortium) of the Long-Form Complaint against Defendant when filing her Short-Form Complaint. See [Short-Form Compl. at 5]. I. BACKGROUND A. Procedural Background This product liability lawsuit stems from a multidistrict litigation (“MDL”) involving the use of transvaginal surgical mesh to treat pelvic organ prolapse and stress urinary incontinence.

The Judicial Panel on Multidistrict Litigation assigned 100,000 of these MDL cases to the Honorable Joseph R. Goodwin, United States District Judge for the U.S. District Court for the Southern District of West Virginia, Charleston Division. Approximately 14,000 of these cases were filed against Defendant, one of the manufacturers of transvaginal surgical mesh. See In Re: C. R. Bard, Inc., Pelvic Repair System Products Liability Litigation, No. 2:10-cv-2187, MDL 2187 (S.D. W. Va.). Judge Goodwin conducted pretrial discovery and motions practice in the cases on an individualized basis. Plaintiff filed her Short-Form Complaint directly in the MDL on July 12, 2013, [Short- Form Compl.], indicating that upon transfer from the MDL her case would be filed with the District of Massachusetts and that she was pursuing only Counts I–VI and VIII of the MDL’s

Long-Form Complaint, [id. at 1, 5]. On October 18, 2018, Defendant filed its motion for partial summary judgment. [ECF No. 42]. On October 25, 2018, Plaintiff filed her opposition, [ECF No. 47], and on November 1, 2018, Defendant filed a reply, [ECF No. 51]. On December 3, 2019, Judge Goodwin issued an order transferring twelve of the fifteen remaining cases assigned to him “to the venues from which they ar[o]se,” including Plaintiff’s case. [ECF No. 55]. B. Factual Background The following facts are not in dispute.2

2 Plaintiff did not provide a statement of facts or dispute the facts alleged by Defendant in her opposition. See [ECF No. 47]. “If a party fails to properly support an assertion of fact or fails to properly address another party’s assertion of fact as required by Rule 56(c), the court may . . . Plaintiff, a resident of Massachusetts, was implanted with Defendant’s Avaulta Solo Anterior Synthetic Support System on October 22, 2008, by Dr. Neeraj Kohli (“Dr. Kohli”) at South Shore Hospital in South Weymouth, Massachusetts. [Short-Form Compl. ¶¶ 1–13]. Though Plaintiff did not independently research the company prior to her surgery, she knew

from Dr. Kohli’s nurse practitioner that the mesh was manufactured by Defendant. [ECF No. 42-2 at 21 (Plaintiff Dep. Tr. at 75:1–16)]. Plaintiff did not know anyone who worked for the Defendant, nor did she speak to anyone at the company prior to her mesh implant surgery. [Id. at 28 (Plaintiff Dep. Tr. at 104:12–16)]. Dr. Kohli had reviewed the Instructions for Use (“IFU”) that accompanied the Avaulta mesh implant, [ECF No. 42-3 at 8 (Dr. Kohli Dep. Tr. at 21:14–19) (“I wouldn’t review the [IFU] with every single [surgery] but . . . we were well aware of the IFU . . . .”)], was aware of the potential risks and side effects of Defendant’s mesh implant, and communicated the potential risks and side effects to Plaintiff prior to her surgery, [id. (Dr. Kohli Dep. Tr. at 21:14–19, 84:14–85:1)]. Dr. Kohli has stated that he believes the care he provided to Plaintiff, using the

Avaulta, was to her benefit, and that the risks were acceptable. [Id. at 37 (Dr. Kohli Dep. Tr. at 135:15–22)]. Plaintiff alleges that, approximately five years after her surgery, she began to experience pelvic pain, weight loss, and an inability to be intimate with her partner, which she attributes to the Avaulta implant. [ECF No. 42-2 at 5 (Plaintiff Dep. Tr. at 11:9–12); ECF No. 8 at 6 (Plaintiff Fact Sheet)].

consider the fact undisputed for purposes of the motion . . . .” Fed. R. Civ. P. 56(e). As a result, the facts are taken from Defendant’s memorandum in support of its motion and are deemed accepted as undisputed by Plaintiff. See [ECF No. 43 at 7–8]. II. LEGAL STANDARD The parties do not dispute that Massachusetts law governs Plaintiff’s claims because she filed her complaint directly in the MDL and her alleged injuries occurred in the Commonwealth. See [ECF No. 43 at 8–9; ECF No. 47 at 1]. When a case is filed directly in an MDL, “[t]he Sixth

and Seventh Circuits and most district courts to have addressed the issue hold that the choice-of- law rules of the district to which the case is eventually transferred for trial should apply, not those of the transferring MDL-designated court.” 17A Moore’s Federal Practice - Civil § 124.30 (2020); see also In re Fresenius Granuflo/Naturalyte Dialysate Prods. Liab. Litig., 76 F. Supp. 3d 294, 304 (D. Mass. 2015) (“I agree with the notion that the proper approach for direct filed cases is to treat them ‘as if they were transferred from a judicial district sitting in the state where the case originated.’” (citation omitted) (quoting In re Yasmin and Yaz Marketing, Sales Practices and Prods. Liab. Litig., No. 3:09-md-02100, 2011 U.S. Dist. LEXIS 39820, at *18 (S.D. Ill. Apr. 12, 2011))). Summary judgment is appropriate where the movant demonstrates that “there is no

genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). “A fact is material if its resolution might affect the outcome of the case under the controlling law.” Cochran v. Quest Software, Inc., 328 F.3d 1, 6 (1st Cir. 2003). “A genuine issue exists as to such a fact if there is evidence from which a reasonable trier could decide the fact either way.” Id. When reviewing the record, the court “must take the evidence in the light most flattering to the party opposing summary judgment, indulging all reasonable inferences in that party’s favor.” Id. The First Circuit has noted that this standard “is favorable to the nonmoving party, but it does not give him a free pass to trial.” Hannon v. Beard, 645 F.3d 45, 48 (1st Cir. 2011). “The factual conflicts upon which he relies must be both genuine and material,” Gomez v. Stop & Shop Supermarket Co., 670 F.3d 395, 397 (1st Cir. 2012), and the court may discount “conclusory allegations, improbable inferences, and unsupported speculation,” Cochran, 328 F.3d at 6 (quoting Medina-Muñoz v. R.J. Reynolds Tobacco Co., 896 F.2d 5, 8 (1st Cir. 1990)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cipollone v. Yale Industrial Products, Inc.
202 F.3d 376 (First Circuit, 2000)
Carmona v. Toledo
215 F.3d 124 (First Circuit, 2000)
Cochran v. Quest Software, Inc.
328 F.3d 1 (First Circuit, 2003)
Vives v. Fajardo
472 F.3d 19 (First Circuit, 2007)
Hannon v. Beard
645 F.3d 45 (First Circuit, 2011)
Gomez v. Stop & Shop Supermarket Co.
670 F.3d 395 (First Circuit, 2012)
Andre Grenier v. Cyanamid Plastics, Inc.
70 F.3d 667 (First Circuit, 1995)
Nansamba v. North Shore Medical Center, Inc.
727 F.3d 33 (First Circuit, 2013)
International Fidelity Insurance v. Wilson
443 N.E.2d 1308 (Massachusetts Supreme Judicial Court, 1983)
Correia v. Firestone Tire & Rubber Co.
446 N.E.2d 1033 (Massachusetts Supreme Judicial Court, 1983)
Hayes v. Ariens Co.
462 N.E.2d 273 (Massachusetts Supreme Judicial Court, 1984)
Guzman v. MRM/ELGIN WILLCOX & GIBBS, INC.
567 N.E.2d 929 (Massachusetts Supreme Judicial Court, 1991)
Colter v. Barber-Greene Co.
525 N.E.2d 1305 (Massachusetts Supreme Judicial Court, 1988)
Enrich v. Windmere Corp.
616 N.E.2d 1081 (Massachusetts Supreme Judicial Court, 1993)

Cite This Page — Counsel Stack

Bluebook (online)
Frady v. C. R. Bard, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/frady-v-c-r-bard-inc-mad-2020.